Exhibition Announcement: Epistra to Exhibit at Pharma DX Expo within INTERPHEX Week 2025
At Our Booth: From Concept Stage to Concrete Solutions
Feel free to consult with us. We look forward to welcoming you.
Exclusive Seminar by CEO Ozawa
Autonomous Optimization of Life Science Experiments Using AI — From Pharmaceuticals to Biomaterials
July 9 (Wed) 12:30-13:00 | Pharma DX Forum, Venue 1 (South Hall 4F)
We will introduce cutting-edge technology and case studies for efficiently solving complex condition searches using AI. From over 60 cases spanning pharmaceutical development to biomaterial manufacturing, we will report on achievements in raw material cost reduction, research period shortening, and assay optimization. We will also share the latest trends in QbD manufacturing automation using AI.
Booth Exhibition Overview
Epistra Accelerate
We will showcase diverse applications of our AI-powered bio-experiment optimization solution.
For Researchers Facing These Challenges
- Conventional design of experiments (DoE) has not delivered expected results
- Quality reproducibility issues during scale-up
- Condition searches are taking too long
We will demonstrate how AI and data analysis solve these challenges through real implementation case studies.
Exhibition Highlights
- Automated optimization of experimental conditions using AI
- Integration examples with lab robots and instruments
- QbD process design support and design space prediction capabilities
Feel Free to Consult With Us
Throughout the event, our staff will be on hand to assist with everything from introductory questions about AI applicability to specific condition optimization requests.
Exhibition Details
- Booth: S23-31
- Dates: July 9-11, 2025 (Wed-Fri)
- Venue: Tokyo Big Sight, South Hall 4F
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.